This site is intended for healthcare professionals
Login
Register
Medical Education
Specialty
Drugs
News
Congress
Search
Menu
Medical Education
Specialty
Drugs
News
Congress
Home
/
Medical Education
/
PARP inhibitor selection in ovarian cancer Learnin...
/
Congress highlights
/
ESMO 2022 videos
/
ESMO 2022: Clinical trial data reveal the impact o...
ESMO 2022: Clinical trial data reveal the impact of PARPis on overall survival at different time points in the natural history of ovarian cancer
Congress highlights
Bookmark
Bookmarked
Top